CLCC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.090400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.329800E-01
Normal-vs-Stage2
6.338800E-01
Normal-vs-Stage3
4.775200E-01
Normal-vs-Stage4
9.108100E-02
Stage1-vs-Stage2
5.078000E-01
Stage1-vs-Stage3
7.216300E-02
Stage1-vs-Stage4
3.263600E-01
Stage2-vs-Stage3
2.147800E-01
Stage2-vs-Stage4
1.419590E-01
Stage3-vs-Stage4
3.767700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.381600E-01
Normal-vs-AfricanAmerican
1.989230E-01
Normal-vs-Asian
9.372600E-01
Caucasian-vs-AfricanAmerican
5.898300E-02
Caucasian-vs-Asian
5.076000E-01
AfricanAmerican-vs-Asian
1.377800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.995000E-01
Normal-vs-Female
5.208600E-01
Male-vs-Female
2.080000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.160620E-01
Normal-vs-Age(41-60Yrs)
2.888200E-01
Normal-vs-Age(61-80Yrs)
7.571800E-01
Normal-vs-Age(81-100Yrs)
8.173800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.964800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.874400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.353760E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.070200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.867780E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.224400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.190200E-01
Normal-vs-Daily Drinker
8.952600E-01
Normal-vs-Weekly Drinker
8.957800E-01
Normal-vs-Occasional Drinker
3.785000E-01
Normal-vs-Social Drinker
3.638000E-01
Non Drinker-vs-Daily Drinker
8.288800E-01
Non Drinker-vs-Weekly Drinker
5.114200E-01
Non Drinker-vs-Occasional Drinker
2.395800E-01
Non Drinker-vs-Social Drinker
1.493450E-01
Daily Drinker-vs-Weekly Drinker
6.446600E-01
Daily Drinker-vs-Occasional Drinker
1.794570E-01
Daily Drinker-vs-Social Drinker
1.202000E-01
Weekly Drinker-vs-Occasional Drinker
1.018570E-01
Weekly Drinker-vs-Social Drinker
8.361800E-02
Occasional Drinker-vs-Social Drinker
6.865800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.808300E-02
Normal-vs-Grade 2
3.300300E-02
Normal-vs-Grade 3
1.742360E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.723400E-01
Grade 1-vs-Grade 3
3.248800E-01
Grade 1-vs-Grade 4
6.808300E-02
Grade 2-vs-Grade 3
8.944200E-01
Grade 2-vs-Grade 4
3.300300E-02
Grade 3-vs-Grade 4
1.742360E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.270400E-01
Normal-vs-NonDiabetic
6.408800E-01
Diabetic-vs-NonDiabetic
1.288790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.639800E-01
Normal-vs-NoPancreatitis
7.241000E-01
Pancreatitis-vs-NoPancreatitis
1.566960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.078400E-01
Normal-vs-N1
6.284000E-01
N0-vs-N1
8.671800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.766800E-01
Normal-vs-TP53-NonMutant
5.656000E-01
TP53-Mutant-vs-TP53-NonMutant
5.574800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
